| 标题 |
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Byoung Chul Cho; Delvys Rodríguez‐Abreu; Maen Hussein; Manuel Cobo; A. Patel; et al 出版日期:2022-05-13 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)